2011 annual financial data

Fate Therapeutics, Inc. 2011 Net margin

Fate Therapeutics, Inc. 2011 net margin with verified reported values.

Direct answer

Net margin was -1,147.61%.

Operating income was -13,293,000 USD and net income was -13,427,000 USD.
Operating cash flow was -12,145,000 USD.

Get free Fate Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,170,000 USD
Operating income
-13,293,000 USD
Net income
-13,427,000 USD
Operating cash flow
-12,145,000 USD